type I diabetes
Diabetes trial disappointment for GSK and Tolerx
March 14, 2011Research and Development DEFEND-1, DEFEND-2, GSK, GlaxoSmithKline, Tolerx, diabetes, otelixizumab, type I diabetes
GSK and Tolerx’s type I diabetes drug otelixizumab has failed to meet its primary endpoint in a late-stage trial. Anti-CD3 …
Novo to develop oral insulin
December 22, 2010Research and Development Emisphere, Novo Nordisk, diabetes, insulin, oral insulin, type I diabetes
Novo Nordisk is to develop an oral formulation of insulin with US biotech company Emisphere Technologies. The New Jersey-based biotech …
Lilly suspends late-stage trials of diabetes drug Protege
October 22, 2010Research and Development, Sales and Marketing MacroGenics, Protege, diabetes, lilly, type I diabetes
Eli Lilly and its partner MacroGenics have suspended phase III trials of their investigational type I diabetes drug Protege after …
Latest content
Jennings becomes President of Beckman Coulter Diagnostics
October 19, 2026
Boyds expands Regulatory Affairs team to support growing demand
October 16, 2026
Sterling doubles ADC manufacturing capacity at Welsh facility
October 16, 2026
Femtosecond laser cuts lung tumour margin assessment time
October 15, 2026
